Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$164.67
At close: May 28 EDT
$164.67
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Tenet Healthcare Analyst Ratings and Price Targets | NYSE:THC | Benzinga
Tenet Healthcare Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Tenet Healthcare Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Truist Securities
Goldman Sachs
Morgan Stanley
Barclays
1calculated from analyst ratings
Analyst Ratings for Tenet Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2025 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | $165 → $180 | Maintains | Buy | Get Alert |
| 05/12/2025 | Buy Now | — | Truist Securities | David Macdonald65% | $175 → $190 | Maintains | Buy | Get Alert |
| 05/05/2025 | Buy Now | — | Goldman Sachs | Jamie Perse63% | $134 → $154 | Maintains | Neutral | Get Alert |
| 05/05/2025 | Buy Now | — | Morgan Stanley | Craig Hettenbach60% | $165 → $175 | Maintains | Overweight | Get Alert |
| 04/30/2025 | Buy Now | — | Barclays | Andrew Mok56% | $161 → $171 | Maintains | Overweight | Get Alert |
| 04/30/2025 | Buy Now | — | RBC Capital | Ben Hendrix59% | $183 → $189 | Maintains | Outperform | Get Alert |
| 04/30/2025 | Buy Now | — | UBS | A.J. Rice70% | $217 → $230 | Maintains | Buy | Get Alert |
| 04/15/2025 | Buy Now | — | Baird | Michael Ha38% | $153 → $137 | Downgrade | Outperform → Neutral | Get Alert |
| 04/09/2025 | Buy Now | — | Guggenheim | Jason Cassorla51% | → $165 | Initiates | → Buy | Get Alert |
| 03/26/2025 | Buy Now | — | Morgan Stanley | Craig Hettenbach60% | → $165 | Initiates | → Overweight | Get Alert |
| 02/13/2025 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $177 → $177 | Reiterates | Overweight → Overweight | Get Alert |
| 02/13/2025 | Buy Now | — | Barclays | Andrew Mok56% | $190 → $161 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | — | Keybanc | Tim Rezvan49% | $200 → $185 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | — | Truist Securities | David Macdonald65% | $190 → $175 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | — | JP Morgan | Benjamin Rossi65% | → $175 | Assumes | → Overweight | Get Alert |
| 12/16/2024 | Buy Now | — | Goldman Sachs | Jamie Perse63% | $196 → $140 | Downgrade | Buy → Neutral | Get Alert |
| 11/25/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $205 → $150 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/22/2024 | Buy Now | — | Raymond James | John Ransom76% | $195 → $195 | Downgrade | Strong Buy → Outperform | Get Alert |
| 11/08/2024 | Buy Now | — | Barclays | Andrew Mok56% | $171 → $190 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $195 → $205 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $168 → $177 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | — | Goldman Sachs | Jamie Perse63% | $173 → $196 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | — | RBC Capital | Ben Hendrix59% | $174 → $183 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $180 → $190 | Reiterates | Buy → Buy | Get Alert |
| 10/30/2024 | Buy Now | — | UBS | A.J. Rice70% | $197 → $217 | Maintains | Buy | Get Alert |
| 10/22/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $175 → $195 | Maintains | Overweight | Get Alert |
| 10/14/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $170 → $180 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor66% | → $200 | Initiates | → Overweight | Get Alert |
| 10/04/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 10/01/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 08/20/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 08/14/2024 | Buy Now | — | UBS | A.J. Rice70% | $180 → $197 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | — | Goldman Sachs | Jamie Perse63% | $156 → $173 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $145 → $175 | Maintains | Overweight | Get Alert |
| 07/29/2024 | Buy Now | — | Barclays | Andrew Mok56% | $156 → $171 | Maintains | Overweight | Get Alert |
| 07/25/2024 | Buy Now | — | Citigroup | Jason Cassorla51% | $139 → $171 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | — | Raymond James | John Ransom76% | $130 → $175 | Maintains | Strong Buy | Get Alert |
| 07/25/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $155 → $170 | Reiterates | Buy → Buy | Get Alert |
| 07/25/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $112 → $168 | Maintains | Overweight | Get Alert |
| 07/15/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $130 → $155 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | — | Barclays | Andrew Mok56% | $147 → $156 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $112 → $112 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $112 → $112 | Reiterates | Overweight → Overweight | Get Alert |
| 07/02/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $112 → $112 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2024 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $150 → $155 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | — | JP Morgan | Lisa Gill55% | $107 → $140 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $126 → $150 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | — | Baird | Michael Ha38% | → $153 | Initiates | → Outperform | Get Alert |
| 05/02/2024 | Buy Now | — | Barclays | Andrew Mok56% | $113 → $147 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | — | Stephens & Co. | Scott Fidel69% | $95 → $122 | Maintains | Equal-Weight | Get Alert |
| 05/01/2024 | Buy Now | — | RBC Capital | Ben Hendrix59% | $109 → $136 | Maintains | Outperform | Get Alert |
| 05/01/2024 | Buy Now | — | UBS | A.J. Rice70% | $137 → $150 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | — | Mizuho | Ann Hynes85% | $118 → $130 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $120 → $130 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2024 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $100 → $126 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $104 → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $105 → $115 | Maintains | Overweight | Get Alert |
| 03/27/2024 | Buy Now | — | Wolfe Research | Justin Lake31% | → $122 | Upgrade | Peer Perform → Outperform | Get Alert |
| 03/11/2024 | Buy Now | — | Mizuho | Ann Hynes85% | $100 → $110 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | — | Barclays | Andrew Mok56% | → $113 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $104 → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 02/15/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $98 → $105 | Maintains | Overweight | Get Alert |
| 02/09/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $92 → $105 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | — | RBC Capital | Ben Hendrix59% | $97 → $109 | Maintains | Outperform | Get Alert |
| 02/09/2024 | Buy Now | — | Mizuho | Ann Hynes85% | $90 → $100 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $94 → $104 | Maintains | Overweight | Get Alert |
| 11/20/2023 | Buy Now | — | Truist Securities | David Macdonald65% | → $92 | Reiterates | Buy → Buy | Get Alert |
| 11/17/2023 | Buy Now | — | JP Morgan | Calvin Sternick47% | $91 → $81 | Maintains | Overweight | Get Alert |
| 11/14/2023 | Buy Now | — | Jefferies | Brian Tanquilut45% | $95 → $85 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | — | Goldman Sachs | Jamie Perse63% | $98 → $85 | Maintains | Buy | Get Alert |
| 11/02/2023 | Buy Now | — | UBS | Andrew Mok56% | $104 → $94 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | — | Raymond James | John Ransom76% | $95 → $90 | Maintains | Strong Buy | Get Alert |
| 10/31/2023 | Buy Now | — | Mizuho | Ann Hynes85% | $94 → $77 | Maintains | Buy | Get Alert |
| 10/31/2023 | Buy Now | — | RBC Capital | Ben Hendrix59% | $87 → $72 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $83 → $71 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | $76 → $94 | Maintains | Overweight | Get Alert |
| 08/14/2023 | Buy Now | — | Goldman Sachs | Jamie Perse63% | $89 → $98 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | — | Credit Suisse | A.J. Rice70% | $92 → $98 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | — | Raymond James | John Ransom76% | $85 → $95 | Maintains | Strong Buy | Get Alert |
| 08/01/2023 | Buy Now | — | UBS | Andrew Mok56% | $95 → $104 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | — | RBC Capital | Ben Hendrix59% | $84 → $87 | Maintains | Outperform | Get Alert |
| 08/01/2023 | Buy Now | — | Stephens & Co. | Scott Fidel69% | $87 → $89 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | Buy Now | — | Citigroup | Jason Cassorla51% | $83 → $90 | Maintains | Buy | Get Alert |
| 07/11/2023 | Buy Now | — | Mizuho | Ann Hynes85% | $81 → $94 | Maintains | Buy | Get Alert |
| 06/20/2023 | Buy Now | — | Truist Securities | Ryan MacDonald60% | $84 → $92 | Maintains | Buy | Get Alert |
| 06/14/2023 | Buy Now | — | Jefferies | Brian Tanquilut45% | → $95 | Reiterates | → Buy | Get Alert |
| 05/16/2023 | Buy Now | — | Mizuho | Ann Hynes85% | $78 → $81 | Maintains | Buy | Get Alert |
| 04/26/2023 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $65 → $81 | Maintains | Buy | Get Alert |
| 04/26/2023 | Buy Now | — | Truist Securities | Ryan MacDonald60% | $74 → $84 | Maintains | Buy | Get Alert |
| 04/26/2023 | Buy Now | — | RBC Capital | Ben Hendrix59% | $73 → $84 | Maintains | Outperformer | Get Alert |
| 04/26/2023 | Buy Now | — | Raymond James | John Ransom76% | $72 → $85 | Maintains | Strong Buy | Get Alert |
| 04/26/2023 | Buy Now | — | Stephens & Co. | Scott Fidel69% | $64 → $77 | Maintains | Equal-Weight | Get Alert |
| 04/26/2023 | Buy Now | — | Barclays | Steve Valiquette53% | $70 → $105 | Maintains | Overweight | Get Alert |
| 04/21/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James50% | → $73 | Initiates | → Overweight | Get Alert |
| 04/19/2023 | Buy Now | — | JP Morgan | Calvin Sternick47% | → $72 | Initiates | → Overweight | Get Alert |
| 02/22/2023 | Buy Now | — | Stephens & Co. | Scott Fidel69% | $60 → $64 | Maintains | Equal-Weight | Get Alert |
| 02/17/2023 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $59 → $68 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | — | Mizuho | Ann Hynes85% | $60 → $78 | Maintains | Buy | Get Alert |
| 02/14/2023 | Buy Now | — | UBS | Andrew Mok56% | $47 → $78 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Tenet Healthcare (THC) stock?
The latest price target for Tenet Healthcare (NYSE:THC) was reported by B of A Securities on May 14, 2025. The analyst firm set a price target for $180.00 expecting THC to rise to within 12 months (a possible 9.31% upside). 49 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tenet Healthcare (THC)?
The latest analyst rating for Tenet Healthcare (NYSE:THC) was provided by B of A Securities, and Tenet Healthcare maintained their buy rating.
When was the last upgrade for Tenet Healthcare (THC)?
The last upgrade for Tenet Healthcare Corp happened on March 27, 2024 when Wolfe Research raised their price target to $122. Wolfe Research previously had a peer perform for Tenet Healthcare Corp.
When was the last downgrade for Tenet Healthcare (THC)?
The last downgrade for Tenet Healthcare Corp happened on April 15, 2025 when Baird changed their price target from $153 to $137 for Tenet Healthcare Corp.
When is the next analyst rating going to be posted or updated for Tenet Healthcare (THC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenet Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenet Healthcare was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
Is the Analyst Rating Tenet Healthcare (THC) correct?
While ratings are subjective and will change, the latest Tenet Healthcare (THC) rating was a maintained with a price target of $165.00 to $180.00. The current price Tenet Healthcare (THC) is trading at is $164.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
